Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions

被引:312
作者
Wu, Ke [1 ]
Kryczek, Ilona [1 ]
Chen, Lieping [2 ]
Zou, Weiping [1 ]
Welling, Theodore H. [1 ]
机构
[1] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[2] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
CHRONIC HEPATITIS-B; PROGRAMMED-DEATH-1; EXPRESSION; PD-1; UP-REGULATION; B7-H1; TUMOR; BLOCKADE; IMMUNITY; TOLERANCE; LIVER;
D O I
10.1158/0008-5472.CAN-09-0901
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B7-H1 is a recently identified B7 family member that, along with one of its receptors, programmed death-1 (PD-1), has been involved in multiple immunopathologic scenarios. However, the nature of B7-H1 and PD-1 in human hepatocellular carcinoma (HCC) remains poorly defined. We investigated the expression and functional relevance of this pathway in patients with HCC. We showed that B7-H1 expression on Kupffer cells (KC) was increased in tumor tissues compared with surrounding nontumor liver tissues in patients wit H and this correlated with poorer survival. Coculture of HCC cells with monocytes showed that tumor-associated interleukin-10 contributed to the induction of B7-H1 in the HCC environment. We further observed that the levels of PD-1(+)CD8(+) T cells were higher in tumor tissues than in norittimor tissues. B7-H1(+) KCs and PD-1(+) T cells were colocalized in the HCC stroma. PD-1(+)CD8(+) T cells had decreased proliferative ability and effector function as shown by reduced granule and cytokine expression compared with PD-1(-) Tcells. Importantly, blocking KC B7-H1 interaction with PD-1(+)CD8(+) cells using neutralizing antibodies recovered effector T-cell function. Our data indicate that the B7-H1/PD-1 axis contributes to immune suppression in human HCC, with blockade of this pathway carrying important therapeutic implications. [Cancer Res 2009;69(20):8067-75]
引用
收藏
页码:8067 / 8075
页数:9
相关论文
共 31 条
[1]   B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells [J].
Azuma, Takeshi ;
Yao, Sheng ;
Zhu, Gefeng ;
Flies, Andrew S. ;
Flies, Sarah J. ;
Chen, Lieping .
BLOOD, 2008, 111 (07) :3635-3643
[2]   Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses [J].
Butte, Manish J. ;
Keir, Mary E. ;
Phamduy, Theresa B. ;
Sharpe, Arlene H. ;
Freeman, Gordon J. .
IMMUNITY, 2007, 27 (01) :111-122
[3]   B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B [J].
Chen, Liangen ;
Zhang, Zheng ;
Chen, Weiwei ;
Zhang, Zhidong ;
Li, Yonggang ;
Shi, Ming ;
Zhang, Jiyuan ;
Chen, Lieping ;
Wang, Shengdian ;
Wang, Fu-Sheng .
JOURNAL OF IMMUNOLOGY, 2007, 178 (10) :6634-6641
[4]   Cellular and molecular mechanisms of liver tolerance [J].
Crispe, Ian N. ;
Giannandrea, Matthew ;
Klein, Ingo ;
John, Beena ;
Sampson, Bradford ;
Wuensch, Sherry .
IMMUNOLOGICAL REVIEWS, 2006, 213 :101-118
[5]   Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity [J].
Curiel, TJ ;
Wei, S ;
Dong, HD ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Krzysiek, R ;
Knutson, KL ;
Daniel, B ;
Zimmermann, MC ;
David, O ;
Burow, M ;
Gordon, A ;
Dhurandhar, N ;
Myers, L ;
Berggren, R ;
Hemminki, A ;
Alvarez, RD ;
Emilie, D ;
Curiel, DT ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2003, 9 (05) :562-567
[6]   PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression [J].
Day, Cheryl L. ;
Kaufmann, Daniel E. ;
Kiepiela, Photini ;
Brown, Julia A. ;
Moodley, Eshia S. ;
Reddy, Sharon ;
Mackey, Elizabeth W. ;
Miller, Joseph D. ;
Leslie, Alasdair J. ;
DePierres, Chantal ;
Mncube, Zenele ;
Duraiswamy, Jaikumar ;
Zhu, Baogong ;
Eichbaum, Quentin ;
Altfeld, Marcus ;
Wherry, E. John ;
Coovadia, Hoosen M. ;
Goulder, Philip J. R. ;
Klenerman, Paul ;
Ahmed, Rafi ;
Freeman, Gordon J. ;
Walker, Bruce D. .
NATURE, 2006, 443 (7109) :350-354
[7]   B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes [J].
Dong, HD ;
Zhu, GF ;
Tamada, K ;
Flies, DB ;
van Deursen, JMA ;
Chen, LP .
IMMUNITY, 2004, 20 (03) :327-336
[8]  
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[9]   Diagnosis and treatment of hepatocellular carcinoma [J].
El-Serag, Hashem B. ;
Marrero, Jorge A. ;
Rudolph, Lenhard ;
Reddy, K. Rajender .
GASTROENTEROLOGY, 2008, 134 (06) :1752-1763
[10]   Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion [J].
Evans, Alexander ;
Riva, Antonio ;
Cooksley, Helen ;
Phillips, Sandra ;
Puranik, Smrithi ;
Nathwani, Amit ;
Brett, Sara ;
Chokshi, Shilpa ;
Naoumov, Nikolai V. .
HEPATOLOGY, 2008, 48 (03) :759-769